Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71 (3), 209–249 (2021).ArticleÂ
PubMedÂ
Google ScholarÂ
Mizrahi, J. D., Surana, R., Valle, J. W. & Shroff, R. T. Pancreatic cancer. Lancet. 395 (10242), 2008–2020 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Liang, H. Y., Chen, T., Yan, H. T., Huang, Z. & Tang, L. J. Berberine ameliorates severe acute pancreatitis–induced intestinal barrier dysfunction via a myosin light chain phosphorylation–dependent pathway. Mol. Med. Rep.9 (5), 1827–1833 (2014).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Bansod, S., Doijad, N. & Godugu, C. Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization. Toxicol. Appl. Pharmacol.403, 115162 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Yin, J., Xing, H. & Ye, J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 57 (5), 712–717 (2008).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yerra, V. G., Kalvala, A. K., Sherkhane, B., Areti, A. & Kumar, A. Adenosine monophosphate-activated protein kinase modulation by berberine attenuates mitochondrial deficits and redox imbalance in experimental diabetic neuropathy. Neuropharmacology. 131, 256–270 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Goel, A. Current understanding and future prospects on Berberine for anticancer therapy. Chem. Biol. Drug Des.102 (1), 177–200 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Abrams, S. L. et al. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. Adv. Biol. Regul.71, 172–182 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Liu, J., Luo, X., Guo, R., Jing, W. & Lu, H. Cell Metabolomics reveals Berberine-inhibited pancreatic Cancer cell viability and metastasis by regulating citrate metabolism. J. Proteome Res.19 (9), 3825–3836 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Pinto-Garcia, L., Efferth, T., Torres, A., Hoheisel, J. D. & Youns, M. Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells. Planta Med.76 (11), 1155–1161 (2010).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Gu, S. et al. Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles. Life Sci.257, 118122 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Yu, G., Wang, L. G., Yan, G. R. & He, Q. Y. DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics. 31 (4), 608–609 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res.28 (1), 27–30 (2000).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res.51 (D1), D587–D592 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci.28 (11), 1947–1951 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Xie, Z. et al. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc.1 (3), e90 (2021).ArticleÂ
MathSciNetÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res.43 (7), e47 (2015).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Gustavsson, E. K., Zhang, D., Reynolds, R. H., Garcia-Ruiz, S. & Ryten, M. Ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics. 38 (15), 3844–3846 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A. 102 (43), 15545–15550 (2005).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform.9, 559 (2008).ArticleÂ
Google ScholarÂ
Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res.51 (D1), D638–D646 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Csardi, G. & Nepusz, T. The igraph software package for complex network research. InterJournal Complex. Syst.1695, 1–9 (2005).
Google ScholarÂ
Robin, X. et al. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinform.12, 77 (2011).ArticleÂ
Google ScholarÂ
Alba, A. C. et al. Discrimination and calibration of clinical prediction models: users’ guides to the Medical Literature. JAMA. 318 (14), 1377 (2017).ArticleÂ
PubMedÂ
Google ScholarÂ
Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. Profiling Tumor infiltrating Immune cells with CIBERSORT. Methods Mol. Biol.1711, 243–259 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell. 184 (13), 3573–3587e29 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods. 16 (12), 1289–1296 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol.20 (2), 163–172 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhu, Y. et al. Tissue-Resident macrophages in Pancreatic Ductal Adenocarcinoma Originate from embryonic hematopoiesis and promote Tumor Progression. Immunity. 47 (2), 323–338e6 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Helm, O. et al. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis: role of macrophages in pancreatic cancer. Int. J. Cancer. 135 (4), 843–861 (2014).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Christenson, E. S., Jaffee, E. & Azad, N. S. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future. Lancet Oncol.21 (3), e135–e145 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhang, A., Miao, K., Sun, H. & Deng, C. X. Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance. Int. J. Biol. Sci.18 (7), 3019–3033 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Suvà , M. L., Tirosh, I. & Single-Cell, R. N. A. Sequencing in Cancer: lessons learned and Emerging challenges. Mol. Cell.75 (1), 7–12 (2019).ArticleÂ
PubMedÂ
Google ScholarÂ
Preissl, S., Gaulton, K. J. & Ren, B. Characterizing cis-regulatory elements using single-cell epigenomics. Nat. Rev. Genet.24 (1), 21–43 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Labori, K. J. et al. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – a population-based cohort study. Acta Oncol.55 (3), 265–277 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Ansari, D., Gustafsson, A. & Andersson, R. Update on the management of pancreatic cancer: surgery is not enough. World J. Gastroenterol.21 (11), 3157–3165 (2015).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Daamen, L. A. et al. Postoperative surveillance of pancreatic cancer patients. Eur. J. Surg. Oncol.45 (10), 1770–1777 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Andersson, R. et al. Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions. Scand. J. Gastroenterol.44 (7), 782–786 (2009).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Samadi, P. et al. Berberine: a novel therapeutic strategy for cancer. IUBMB Life. 72 (10), 2065–2079 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Devarajan, N. et al. Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies. Phytother. Res.35 (6), 3059–3077 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Park, S. H., Sung, J. H. & Chung, N. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2. Mol. Cell. Biochem.394 (1–2), 209–215 (2014).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Park, S. H., Sung, J. H., Kim, E. J. & Chung, N. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines. Braz J. Med. Biol. Res.48 (2), 111–119 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Cheng, C. S. et al. Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression. Clin. Transl Med.11 (6), e467 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Okuno, K. et al. Berberine overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt signaling in pancreatic ductal adenocarcinoma. Pharmaceuticals. 15 (10), 1199 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Abrams, S. L. et al. Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53. Adv. Biol. Regul.83, 100840 (2022).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Spreafico, R., Soriaga, L. B., Grosse, J., Virgin, H. W. & Telenti, A. Advances in Genomics for Drug Development. Genes (Basel). 11 (8), 942 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Heath, J. R., Ribas, A. & Mischel, P. S. Single-cell analysis tools for drug discovery and development. Nat. Rev. Drug Discov. 15 (3), 204–216 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kazi, A. et al. Global Phosphoproteomics Reveal CDK suppression as a vulnerability to KRas Addiction in Pancreatic Cancer. Clin. Cancer Res.27 (14), 4012–4024 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Huang, J. et al. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer. Gut. 70 (5), 890–899 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wijnen, R. et al. Cyclin dependent Kinase-1 (CDK-1) inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC). Cancers (Basel). 13 (17), 4389 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Piao, J. et al. High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma. Gene. 701, 15–22 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Dong, S., Huang, F., Zhang, H. & Chen, Q. Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma. Biosci. Rep.39 (2), BSR20182306 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Fang, L., Du, W. W., Awan, F. M., Dong, J. & Yang, B. B. The circular RNA circ-Ccnb1 dissociates Ccnb1/Cdk1 complex suppressing cell invasion and tumorigenesis. Cancer Lett.459, 216–226 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Sano, M. et al. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3’-oxime and 5-methoxyindirubin 3’-oxime in vitro and in vivo. Cancer Lett.397, 72–82 (2017).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Zhang, H. et al. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. J. Cell. Physiol.234 (1), 619–631 (2018).ArticleÂ
ADSÂ
PubMedÂ
Google ScholarÂ
Zhu, L. et al. Characterization of stem-like circulating tumor cells in pancreatic Cancer. Diagnostics (Basel). 10 (5), 305 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Pei, Y. F., Yin, X. M. & Liu, X. Q. TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway. Biochim. Biophys. Acta Mol. Basis Dis.1864 (1), 197–207 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Tanaka, T. et al. Molecular pathogenesis of pancreatic ductal adenocarcinoma: impact of miR-30c-5p and miR-30c-2-3p regulation on oncogenic genes. Cancers (Basel). 12 (10), 2731 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Bryant, V. L., Elias, R. M., McCarthy, S. M., Yeatman, T. J. & Alexandrow, M. G. Suppression of Reserve MCM Complexes Chemosensitizes to Gemcitabine and 5-Fluorouracil. Mol. Cancer Res.13 (9), 1296–1305 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kayed, H. et al. Regulation and functional role of the runt-related transcription factor-2 in pancreatic cancer. Br. J. Cancer. 97 (8), 1106–1115 (2007).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chen, M. et al. NUSAP1-LDHA-Glycolysis-lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma. Cancer Lett.567, 216285 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Zhang, Z. & Zhang, H. J. Glycometabolic rearrangements-aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potential. Expert Opin. Ther. Targets. 25 (12), 1077–1093 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Zhang, Z. et al. Targeting Plk1 sensitizes pancreatic Cancer to Immune Checkpoint Therapy. Cancer Res.82 (19), 3532–3548 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Mahajan, U. M. et al. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer. Gut. 65 (11), 1838–1849 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Gustin, P., Lekeux, P., Lomba, F. & Clercx, C. Mechanical properties of excised calf lungs. Res. Vet. Sci.42 (3), 272–276 (1987).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Yang, J., Li, Y., Sun, Z. & Zhan, H. Macrophages in pancreatic cancer: an immunometabolic perspective. Cancer Lett.498, 188–200 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Spek, C. A., Aberson, H. L. & Duitman, J. Macrophage C/EBPδ drives Gemcitabine, but not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer cells in a deoxycytidine-dependent manner. Biomedicines. 10 (2), 219 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhang, R. et al. Pancreatic cancer-educated macrophages protect cancer cells from complement-dependent cytotoxicity by up-regulation of CD59. Cell. Death Dis.10 (11), 836 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kaneda, M. M. et al. Macrophage PI3Kγ drives pancreatic ductal adenocarcinoma progression. Cancer Discov. 6 (8), 870–885 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Tekin, C., Aberson, H. L., Bijlsma, M. F. & Spek, C. A. Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion. BMC Cancer. 20 (1), 1183 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ